• About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us
Assamese |   Bengali |  
Friday, April 23, 2021
NORTHEAST NOW
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
NORTHEAST NOW
Assamese
Home Health

Researchers find antiviral drug, which can expedite recovery of COVID-19 patients

NE NOW NEWS by NE NOW NEWS
May 16, 2020 12:56 pm
COVID19 vaccine

Representative image.

Share on FacebookShare on Twitter

An international team of researchers has found that an antiviral drug – interferon (IFN)-a2b — can help speed up the recovery of COVID-19 patients.

The study, which is published in the journal Frontiers in Immunology,   revealed that treatment with interferon(IFN)-a2b may significantly accelerate virus clearance and reduce levels of inflammatory proteins in COVID-19 patients.

“Rather than developing a virus-specific antiviral for each new virus outbreak, we should consider interferons as the ‘first responders’ in terms of treatment,” said researcher Dr Eleanor Fish.

Fish, a professor in the University of Toronto in Canada, heads the study.

The research team considered IFN-a therapy for COVID-19 after they demonstrated interferon provided therapeutic benefit during the SARS outbreak of 2002 and 2003.

They found that treatment with this drug, which has been used clinically for many years, significantly reduced the duration of detectable virus in the upper respiratory tract, on average by about seven days.

It also reduced blood levels of interleukin (IL)-6 and C-reactive protein (CRP), two inflammatory proteins found in COVID-19 patients.

For the findings, the researchers conducted this exploratory study on a group of 77 patients with COVID-19 in Wuhan, China.

They represented moderate cases of the disease as none of the patients required intensive care or prolonged oxygen supplementation or intubation.

The researchers said he work provides several important and novel insights into COVID-19 disease, notably that treatment with IFN-a2b can accelerate viral clearance from the upper respiratory tract and also reduce circulating levels of inflammatory factors that are associated with severe COVID-19.

Dr Fish said a randomised clinical trial is a crucial next step.

According to her, a clinical trial with a larger group of infected patients who are randomised to treatment or placebo would further this research.

Another study, published in the journal The Lancet, stated that the two-week course of antiviral therapy that combines the power of three antiviral drugs has shown promise in treating hospitalised patients with mild to moderate COVID-19 virus.

NORTHEAST NOW

Northeast Now is a multi-app based hyper-regional bilingual news portal. Led by a group of professionals, the digital news platform covers every inch of the eight states of northeast India and the five neighbouring countries. It is the first of its kind new media initiative in the northeast, and is based in Guwahati. As the political dynamics in the northeast is intricate and fluid, Northeast Now is always politically neutral.

 
Our Properties
 
  • NORTHEAST NOW ASSAMESE
  • NORTHEAST JOBS
  • NORTHEAST TENDERS
  • INNFINITY
  • About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd

No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd